XTL BIOPHARMACEUTICALS LTD. Cash And Cash Equivalents
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Cash And Cash Equivalents of $371.00 thousand as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-04-30
- 2024-12-31: Cash And Cash Equivalents $371.00K.
- 2023-12-31: Cash And Cash Equivalents $1.40M.
- 2022-12-31: Cash And Cash Equivalents $2.09M.
- 2022-06-30: Cash And Cash Equivalents $2.35M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2024-12-31 | $371.00K 20-F · filed 2025-04-30 |
| 2023-12-31 | $1.40M 20-F · filed 2025-04-30 |
| 2022-12-31 | $2.09M 20-F · filed 2025-04-30 |
| 2022-06-30 | $2.35M 6-K · filed 2022-08-24 |
| 2021-12-31 | $2.97M 20-F · filed 2025-04-30 |
| 2021-06-30 | $2.92M 6-K · filed 2021-08-24 |
| 2020-12-31 | $3.63M 20-F · filed 2023-03-22 |
| 2020-06-30 | $4.03M 6-K · filed 2021-08-24 |
| 2019-12-31 | $4.46M 20-F · filed 2023-03-22 |
| 2019-01-01 | $3.25M 20-F/A · filed 2021-05-19 |
| 2018-12-31 | $3.25M 20-F · filed 2022-03-30 |
| 2017-12-31 | $3.29M 20-F/A · filed 2021-05-19 |
| 2016-12-31 | $2.02M 20-F · filed 2020-03-12 |
| 2015-12-31 | $3.82M 20-F · filed 2019-03-11 |
| 2014-12-31 | $2.16M 20-F · filed 2018-03-15 |